The effect of using virtual reality headsets during minimally invasive adrenal vein blood sampling for endocrinological sampling - a randomized controlled pilot study

The effect of using virtual reality headsets during minimally invasive adrenal vein blood sampling for endocrinological sampling - a randomized controlled pilot study - VR AG

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00036798

Enrollment

Registered

2025-08-13

Start date

2025-09-01

Completion date

Unknown

Last updated

2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

E26.0

Interventions

Group 1: Adrenal vein blood sampling (AVBS) with VR headset Group 2: AVBS withouth VR headset

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Clinically indicated selective adrenal vein blood sampling - signed study consent form

Exclusion criteria

Exclusion criteria: - Contraindication for clinically indicated selective adrenal vein blood sampling - Patient age under 18 years - Migraine with aura - Claustrophobia - Epilepsy - Severe balance disorder - Kinetosis - Acute psychosis

Design outcomes

Primary

Measure	Time frame
1. State-Trait Anxiety Inventory - Trait Version (STAI- T) and State Version (STAI-S)	—

Secondary

Measure	Time frame
2. Likert scale to assess the sensation of pain 3. serum cortisol level 4. vital signs: Blood pressure, pulse, heart rate variability, peripheral oxygen saturation 5. simulator sickness questionnaire (SSQ) (Kennedy et al., 1993) (not in the control group without VR headset) 6. ingroup presence questionnaire (IPQ) (not in the control group without VR headset) 7. examination time, fluoroscopy time, radiation dose 8. survey of the physicians performing the treatment regarding patient communication during the procedure	—

Measure

Time frame

2. Likert scale to assess the sensation of pain 3. serum cortisol level 4. vital signs: Blood pressure, pulse, heart rate variability, peripheral oxygen saturation 5. simulator sickness questionnaire (SSQ) (Kennedy et al., 1993) (not in the control group without VR headset) 6. ingroup presence questionnaire (IPQ) (not in the control group without VR headset) 7. examination time, fluoroscopy time, radiation dose 8. survey of the physicians performing the treatment regarding patient communication during the procedure

—

Countries

Germany

Contacts

Public ContactWibke Uller

Universitätsklinikum Freiburg im Breisgau

wibke.uller@uniklinik-freiburg.de+49 761 270 39540

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026